Literature DB >> 15841184

Ikaros integrates endocrine and immune system development.

Shereen Ezzat1, Rene Mader, ShunJiang Yu, Terry Ning, Philippe Poussier, Sylvia L Asa.   

Abstract

Ikaros transcription factors are essential regulators of lymphopoiesis and the development of the immune system. We now show that Ikaros is expressed in hormone-producing pituitary corticomelanotroph cells, where it binds the proopiomelanocortin promoter and regulates endogenous gene expression. Loss of Ikaros in vivo results in contraction of the pituitary corticomelanotroph population, reduced circulating adrenocorticotrophic hormone levels, and adrenal glucocorticoid insufficiency. While hemopoietic reconstitution failed to correct this hormonal deficit, the phenotype of reduced body weight and diminished survival was rescued by systemic glucocorticoid-hormone administration. Given the established immunomodulatory properties of glucocorticoid hormones, these findings reveal a novel role for Ikaros in orchestrating immune-endocrine development and function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15841184      PMCID: PMC1070405          DOI: 10.1172/JCI22486

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

Review 1.  Haematopoietic cell-fate decisions, chromatin regulation and ikaros.

Authors:  Katia Georgopoulos
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

2.  Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.

Authors:  P Sabbattini; M Lundgren; A Georgiou; C Chow ; G Warnes; N Dillon
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

3.  Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities.

Authors:  J Perdomo; M Holmes; B Chong; M Crossley
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

4.  Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice.

Authors:  S L Asa; K T Coschigano; L Bellush; J J Kopchick; S Ezzat
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

5.  Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary.

Authors:  ShunJiang Yu; Sylvia L Asa; Shereen Ezzat
Journal:  Mol Endocrinol       Date:  2002-05

6.  A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins.

Authors:  B Lamolet; A M Pulichino; T Lamonerie; Y Gauthier; T Brue; A Enjalbert; J Drouin
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

7.  Ikaros-CtIP interactions do not require C-terminal binding protein and participate in a deacetylase-independent mode of repression.

Authors:  Joseph Koipally; Katia Georgopoulos
Journal:  J Biol Chem       Date:  2002-04-16       Impact factor: 5.157

Review 8.  Molecular determinants of pituitary cytodifferentiation.

Authors:  S L Asa; S Ezzat
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

9.  A unique subset of self-specific intraintestinal T cells maintains gut integrity.

Authors:  Philippe Poussier; Terri Ning; Diponkar Banerjee; Michael Julius
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

10.  Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros.

Authors:  S Winandy; L Wu; J H Wang; K Georgopoulos
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

View more
  15 in total

1.  CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.

Authors:  Katie Dorman; Zhongyi Shen; Caimei Yang; Shereen Ezzat; Sylvia L Asa
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 2.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

3.  Ikaros transcription factors: flying between stress and inflammation.

Authors:  George P Chrousos; Tomoshige Kino
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

4.  Normal T-cell development and immune functions in TRIM-deficient mice.

Authors:  Uwe Kölsch; Börge Arndt; Dirk Reinhold; Jonathan A Lindquist; Nicole Jüling; Stefanie Kliche; Klaus Pfeffer; Eddy Bruyns; Burkhart Schraven; Luca Simeoni
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

5.  Molecular specification and patterning of progenitor cells in the lateral and medial ganglionic eminences.

Authors:  Eric S Tucker; Samantha Segall; Deepak Gopalakrishna; Yongqin Wu; Mike Vernon; Franck Polleux; Anthony-Samuel Lamantia
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

Review 6.  Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

Authors:  Sylvia L Asa; Ozgur Mete; Shereen Ezzat
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

7.  Notch target gene deregulation and maintenance of the leukemogenic phenotype do not require RBP-J kappa in Ikaros null mice.

Authors:  Sheila Chari; Sarah E Umetsu; Susan Winandy
Journal:  J Immunol       Date:  2010-05-28       Impact factor: 5.422

8.  Postnatal ablation of POMC neurons induces an obese phenotype characterized by decreased food intake and enhanced anxiety-like behavior.

Authors:  Yona Greenman; Yael Kuperman; Yonat Drori; Sylvia L Asa; Inbal Navon; Oren Forkosh; Shosh Gil; Naftali Stern; Alon Chen
Journal:  Mol Endocrinol       Date:  2013-05-15

9.  An essential role for the hematopoietic transcription factor Ikaros in hypothalamic-pituitary-mediated somatic growth.

Authors:  Shereen Ezzat; Rene Mader; Sandra Fischer; Shunjiang Yu; Cameron Ackerley; Sylvia L Asa
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-07       Impact factor: 11.205

Review 10.  Isolated acquired ACTH deficiency and primary hypothyroidism: a short series and review.

Authors:  M J Hannon; D J O'Halloran
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.